Liver iron concentration and liver impairment in relation to serum IGF-1 levels in thalassaemia major patients: A retrospective study

Liver iron concentration and liver impairment in relation to serum IGF-1 levels in thalassaemia major patients: A retrospective study

Not available

Saved in:

Bibliographic Details
Main Authors:	Vincenzo De Sanctis, Ashraf T Soliman, Giancarlo Candini, Christos Kattamis, Giuseppe Raiola, Heba Elsedfy
Format:	Article
Language:	English
Published:	PAGEPress Publications 2015-02-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/2173
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ACQUIRED HYPOGONADOTROPIC HYPOGONADISM (AHH) IN THALASSAEMIA MAJOR PATIENTS: AN UNDERDIAGNOSED CONDITION?
by: Vincenzo De Sanctis
Published: (2016-01-01)

INSULIN-LIKE GROWTH FACTOR-1 (IGF-1): DEMOGRAPHIC, CLINICAL AND LABORATORY DATA IN 120 CONSECUTIVE ADULT PATIENTS WITH THALASSAEMIA MAJOR
by: V. De Sanctis
Published: (2014-11-01)

The diagnostic approach to central adrenocortical insufficiency (CAI) in thalassemia
by: Vincenzo De Sanctis, et al.
Published: (2016-05-01)

SEVERE LIVER IRON CONCENTRATIONS (LIC) IN 24 PATIENTS WITH Β-THALASSEMIA MAJOR: CORRELATIONS WITH SERUM FERRITIN, LIVER ENZYMES AND ENDOCRINE COMPLICATIONS
by: Vincenzo De Sanctis
Published: (2018-10-01)

CLINICAL AND BIOCHEMICAL DATA OF ADULT THALASSEMIA MAJOR PATIENTS (TM) WITH MULTIPLE ENDOCRINE COMPLICATIONS (MEC) VERSUS TM PATIENTS WITH NORMAL ENDOCRINE FUNCTIONS: A RETROSPECTIVE LONG-TERM STUDY (40 YEARS) IN A TERTIARY CARE CENTER IN ITALY
by: Vincenzo De Sanctis, et al.
Published: (2016-04-01)

Early Markers of Liver Fibrosis in Children with Beta-thalassaemia Major: A Cross-sectional Study
by: Himani Aggarwal, et al.
Published: (2025-01-01)

JADENU® SUBSTITUTING EXJADE® IN IRON OVERLOADED Β- THALASSEMIA MAJOR (BTM) PATIENTS: A PRELIMINARY REPORT OF THE EFFECTS ON THE TOLERABILITY, SERUM FERRITIN LEVEL, LIVER IRON CONCENTRATION AND BIOCHEMICAL PROFILES
by: Vincenzo De Sanctis
Published: (2018-10-01)

Osteoporosis Syndrome in Thalassaemia Major: An Overview
by: Meropi Toumba, et al.
Published: (2010-01-01)

GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE
by: Vincenzo De Sanctis, et al.
Published: (2023-01-01)

LONGITUDINAL STUDY ON LIVER FUNCTIONS IN PATIENTS WITH THALASSEMIA MAJOR BEFORE AND AFTER DEFERASIROX (DFX) THERAPY
by: Ashraf Tawfik Soliman, et al.
Published: (2014-04-01)

LIVER IRON CONTENT (LIC) IN ADULTS WITH NON-TRANSFUSION DEPENDENT SICKLE CELL DISEASE (NT-SCD). CORRELATION WITH SERUM FERRITIN AND LIVER ENZYMES CONCENTRATIONS
by: Vincenzo De Sanctis
Published: (2017-06-01)

Iron induces blood-brain barrier alteration contributing to cognitive impairment in β-thalassaemia mice
by: Parinda Jamrus, et al.
Published: (2025-01-01)

CAN WE PREDICT INCIPIENT DIABETES MELLITUS IN PATIENTS WITH TRANSFUSION DEPENDENT β-THALASSEMIA (β-TDT) REFERRED WITH A HISTORY OF PREDIABETES?
by: Vincenzo De Sanctis, et al.
Published: (2024-01-01)

A Young Adult with Unintentional Acute Parenteral Iron intoxication Treated with Oral Chelation: The Use of Liver Ferriscan.
by: Vincenzo De Sanctis
Published: (2017-01-01)

DOES INSULIN LIKE GROWTH FACTOR-1 (IGF-1) DEFICIENCY HAVE A “PROTECTIVE” ROLE IN THE DEVELOPMENT OF DIABETIC RETINOPATHY IN THALASSEMIA MAJOR PATIENTS?
by: Vincenzo De Sanctis
Published: (2015-05-01)

THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA
by: George J Kontoghiorghes, et al.
Published: (2020-01-01)

Study of long-acting vs daily growth hormone: peak levels, AUC, action duration, and IGF-1
by: Ashraf Soliman, et al.
Published: (2024-12-01)

FINAL HEIGHT AND ENDORINE COMPLICATIONS IN PATIENTS WITH β-THALASSSEMIA INTERMEDIA: OUR EXPERIENCE IN NON-TRANSFUSED VERSUS INFREQUENTLY TRANSFUSED PATIENTS AND CORRELATIONS WITH LIVER IRON CONTENT
by: Vincenzo De Sanctis, et al.
Published: (2019-04-01)

THALASSAEMIA INTERMEDIA : AN UPDATE
by: Ali Taher, et al.
Published: (2009-08-01)

THALASSAEMIA INTERMEDIA : AN UPDATE
by: Maria Domenica Cappellini, et al.
Published: (2009-06-01)

GLUCOSE METABOLISM AND INSULIN RESPONSE TO ORAL GLUCOSE TOLERANCE TEST (OGTT) IN PREPUBERTAL PATIENTS WITH TRANSFUSION DEPENDENT Β-THALASSEMIA (TDT): A LONG-TERM RETROSPECTIVE ANALYSIS
by: Vincenzo De Sanctis, et al.
Published: (2021-08-01)

Homozygous Delta-Beta Thalassaemia With Alpha Thalassaemia and Erythrocytosis- a Rare Case Report
by: Hala Shokr, et al.
Published: (2024-11-01)

Effectiveness and Safety of Sitagliptin in Patients with Beta-thalassaemia Major and Diabetes Mellitus: A Case Series
by: Shahrzad Zonoozi
Published: (2017-01-01)

THALASSAEMIA AND ABERRATIONS OF GROWTH AND PUBERTY
by: Andreas Kyriakou, et al.
Published: (2009-07-01)

Observational study on the current status of thalassaemia in Malaysia: a report from the Malaysian Thalassaemia Registry
by: Hishamshah Mohd Ibrahim, et al.
Published: (2020-06-01)

Association of Beta-Thalassaemia and Hypogonadotropic Hypogonadism
by: Angela Vidal, et al.
Published: (2022-01-01)

Iron Chelation Therapy with Deferasirox Results in Improvement of Liver Enzyme Level in Patients with Iron Overload-Associated Liver Dysfunction
by: Yasuo Miura, et al.
Published: (2010-01-01)

Introducing a new histologic scoring system for iron deposition in liver in thalassemia major, compared with atomic absorption spectrometry
by: Fatemeh Elham Mahjoub, et al.
Published: (2014-08-01)

THE FREQUENCY OF ADRENAL INSUFFICIENCY IN ADOLESCENTS AND YOUNG ADULTS WITH THALASSEMIA MAJOR VERSUS THALASSEMIA INTERMEDIA IN IRAN
by: Sara Matin, et al.
Published: (2014-08-01)

Hepatic and renal functions of paediatric patients with thalassaemia: a cross-sectional study from two large thalassaemia centres in Sri Lanka
by: Meranthi Fernando, et al.
Published: (2025-02-01)

Association between Growth Hormone and Insulin-like Growth Factor-1 (IGF-1) Levels, Liver Function and Short-Term Survival of Paediatric Liver Recipients
by: R. M. Kurabekova, et al.
Published: (2020-09-01)

Copper Deficiency in Sheep with High Liver Iron Accumulation
by: Isadora Karolina Freitas de Sousa, et al.
Published: (2012-01-01)

Liver Failure with Marked Hyperferritinemia: ‘Ironing Out’ the Diagnosis
by: Susan E Natsheh, et al.
Published: (2001-01-01)

THE ICET-A RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF DISTURBANCES OF GLUCOSE HOMEOSTASIS IN THALASSEMIA MAJOR PATIENTS
by: Vincenzo De Sanctis
Published: (2016-10-01)

VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE
by: Ashraf Tawfik Soliman
Published: (2013-09-01)

Iron depletion in “metabolic fatty liver syndromes”: a strong biological rationale with disappointing liver outcomes
by: Amedeo Lonardo
Published: (2023-08-01)

CORRELATION OF TRANSIENT ELASTOGRAPHY WITH LIVER IRON CONCENTRATION, AND SERUM FERRITIN LEVELS IN PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA MAJOR PATIENTS FROM OMAN
by: Hammad Khan, et al.
Published: (2023-08-01)

MicroRNA-28-5p Regulates Liver Cancer Stem Cell Expansion via IGF-1 Pathway
by: Qing Xia, et al.
Published: (2019-01-01)

Late-onset male hypogonadism and fertility potential in thalassemia major patients: Two emerging issues
by: Vincenzo De Sanctis
Published: (2015-07-01)

Minimum proportion of future liver remnant in safe major hepatopancreatoduodenectomy
by: Kentaro Umemura, et al.
Published: (2025-01-01)